These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 15256107

  • 1. [Distinction between benign and malignant pheochromocytomas].
    Liu TH, Chen YJ, Wu SF, Gao J, Jiang WJ, Lu ZH, Guan J, Wei SZ, Luo YF, Cao JL, Wan JW.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):198-202. PubMed ID: 15256107
    [Abstract] [Full Text] [Related]

  • 2. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM, Komorowski RA, Wilson SD, Demeure MJ, Zhu YR.
    Cancer; 1999 Oct 15; 86(8):1583-9. PubMed ID: 10526289
    [Abstract] [Full Text] [Related]

  • 3. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
    Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M, Ghossein RA.
    Surgery; 2008 Jun 15; 143(6):759-68. PubMed ID: 18549892
    [Abstract] [Full Text] [Related]

  • 4. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
    Feng C, Li HZ, Yan WG, Gao JG, Xu WF, Luo YF, Cao JL.
    Zhonghua Wai Ke Za Zhi; 2007 Dec 15; 45(24):1697-700. PubMed ID: 18476530
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
    Gupta D, Shidham V, Holden J, Layfield L.
    Appl Immunohistochem Mol Morphol; 2000 Dec 15; 8(4):267-74. PubMed ID: 11127918
    [Abstract] [Full Text] [Related]

  • 6. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE, Xu D, Höög A, Enberg U, Hou M, Pisa P, Gruber A, Larsson C, Bäckdahl M.
    Mod Pathol; 2003 Mar 15; 16(3):246-55. PubMed ID: 12640105
    [Abstract] [Full Text] [Related]

  • 7. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
    Korpershoek E, Stobbe CK, van Nederveen FH, de Krijger RR, Dinjens WN.
    Endocr Relat Cancer; 2010 Sep 15; 17(3):653-62. PubMed ID: 20488782
    [Abstract] [Full Text] [Related]

  • 8. Elevated levels of telomerase activity in malignant pheochromocytoma.
    Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K.
    Cancer; 1998 Jan 01; 82(1):176-9. PubMed ID: 9428495
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.
    Nagura S, Katoh R, Kawaoi A, Kobayashi M, Obara T, Omata K.
    Mod Pathol; 1999 Dec 01; 12(12):1107-11. PubMed ID: 10619262
    [Abstract] [Full Text] [Related]

  • 10. Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas.
    Petri BJ, Speel EJ, Korpershoek E, Claessen SM, van Nederveen FH, Giesen V, Dannenberg H, van der Harst E, Dinjens WN, de Krijger RR.
    Mod Pathol; 2008 Apr 01; 21(4):407-13. PubMed ID: 18223555
    [Abstract] [Full Text] [Related]

  • 11. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
    Guillemot J, Thouënnon E, Guérin M, Vallet-Erdtmann V, Ravni A, Montéro-Hadjadje M, Lefebvre H, Klein M, Muresan M, Seidah NG, Anouar Y, Yon L.
    J Mol Endocrinol; 2012 Apr 01; 48(2):115-27. PubMed ID: 22217803
    [Abstract] [Full Text] [Related]

  • 12. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG, Giordano TJ, Braun T, Oberman HA.
    Mod Pathol; 2001 Mar 01; 14(3):185-90. PubMed ID: 11266524
    [Abstract] [Full Text] [Related]

  • 13. [Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases].
    Jiang CX, Zeng Z, Wang T, Liu X, Liu R, Li Y.
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov 01; 40(11):762-6. PubMed ID: 22336161
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paragangliomas.
    Pang LC, Tsao KC.
    Arch Pathol Lab Med; 1993 Nov 01; 117(11):1142-7. PubMed ID: 8239937
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of human telomerase catalytic subunit mRNA by in situ hybridization in pheochromocytomas.
    Luo Z, Li J, Qin Y, Ma Y, Liang X, Xian J, Lu D, Wei M, Yang JY, Yang MQ, He Z.
    Endocr Pathol; 2006 Nov 01; 17(4):387-98. PubMed ID: 17525487
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.
    Tavangar SM, Shojaee A, Moradi Tabriz H, Haghpanah V, Larijani B, Heshmat R, Lashkari A, Azimi S.
    Pathol Res Pract; 2010 May 15; 206(5):305-9. PubMed ID: 20189725
    [Abstract] [Full Text] [Related]

  • 17. Histological features, Ki-67 and Bcl-2 immunohistochemical expression and their correlation with the aggressiveness of pheochromocytomas.
    Jovanovic R, Kostadinova-Kunovska S, Bogoeva B, Spasevska L, Petrusevska G.
    Prilozi; 2012 May 15; 33(2):23-40. PubMed ID: 23425867
    [Abstract] [Full Text] [Related]

  • 18. Survivin: a novel neuroendocrine marker for pheochromocytoma.
    Koch CA, Vortmeyer AO, Diallo R, Poremba C, Giordano TJ, Sanders D, Bornstein SR, Chrousos GP, Pacak K.
    Eur J Endocrinol; 2002 Mar 15; 146(3):381-8. PubMed ID: 11888845
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine markers and sustentacular cell count in benign and malignant pheochromocytomas - a comparative study.
    Białas M, Okoń K, Dyduch G, Ciesielska-Milian K, Buziak M, Hubalewska-Dydejczyk A, Sobrinho-Simoes M.
    Pol J Pathol; 2013 Jun 15; 64(2):129-35. PubMed ID: 23900871
    [Abstract] [Full Text] [Related]

  • 20. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
    Babinska A, Sworczak K, Wisniewski P, Nałecz A, Jaskiewicz K.
    Exp Clin Endocrinol Diabetes; 2008 Apr 15; 116(4):246-51. PubMed ID: 18393131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.